Does EVEROLIMUS Cause Recurrent cancer? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Recurrent cancer have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.2% of all adverse event reports for EVEROLIMUS.
71
Reports of Recurrent cancer with EVEROLIMUS
0.2%
of all EVEROLIMUS reports
10
Deaths
22
Hospitalizations
How Dangerous Is Recurrent cancer From EVEROLIMUS?
Of the 71 reports, 10 (14.1%) resulted in death, 22 (31.0%) required hospitalization.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which EVEROLIMUS Alternatives Have Lower Recurrent cancer Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE